Genetically engineered human immunodeficiency virus-like particles with modified chimeric envelope glycoproteins containing influenza virus transmembrane spanning domains
Rovinski, B.; Cao, S X.; Yao, F L.; Persson, R.; Klein, M.H.
Official Gazette of the United States Patent and Trademark Office Patents 1220(2): 1502
1999
ISSN/ISBN: 0098-1133
Accession: 034987115
PDF emailed within 1 workday: $29.90
Related References
Rovinski, B.; Haynes, J.R.; Cao, S.X.; James, O.; Sia, C.; Zolla-Pazner, S.; Matthews, T.J.; Klein, M.H. 1992: Expression and characterization of genetically engineered human immunodeficiency virus-like particles containing modified envelope glycoproteins: implications for development of a cross-protective AIDS vaccine Journal of Virology 66(7): 4003-4012Wang, B-Zhong.; Liu, W.; Kang, S-Moo.; Alam, M.; Huang, C.; Ye, L.; Sun, Y.; Li, Y.; Kothe, D.L.; Pushko, P.; Dokland, T.; Haynes, B.F.; Smith, G.; Hahn, B.H.; Compans, R.W. 2007: Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles Journal of Virology 81(20): 10869-10878
Katz, E.; Wolffe, E.J.; Moss, B. 1997: The cytoplasmic and transmembrane domains of the vaccinia virus B5R protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions Journal of Virology 71(4): 3178-3187
Rey, M.A.; Laurent, A.G.; McClure, J.; Krust, B.; Montagnier, L.; Hovanessian, A.G. 1990: Transmembrane envelope glycoproteins of human immunodeficiency virus type 2 and simian immunodeficiency virus SIV-mac exist as homodimers Journal of Virology 64(2): 922-926
Deml, L.; Schirmbeck, R.; Reimann, J.; Wolf, H.; Wagner, R. 1997: Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies Virology 235(1): 26-39
Montefiori, D.C.; Reimann, K.A.; Wyand, M.S.; Manson, K.; Lewis, M.G.; Collman, R.G.; Sodroski, J.G.; Bolognesi, D.P.; Letvin, N.L. 1998: Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1 Journal of Virology 72(4): 3427-3431
Deml, L.; Kratochwil, G.; Osterrieder, N.; Knüchel, R.; Wolf, H.; Wagner, R. 1997: Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain Virology 235(1): 10-25
Ciczora, Y.; Callens, N.; Penin, F.ço.; Pécheur, E.-I.; Dubuisson, J. 2007: Transmembrane domains of hepatitis C virus envelope glycoproteins: residues involved in E1E2 heterodimerization and involvement of these domains in virus entry Journal of Virology 81(5): 2372-2381
Vincent, M.J.; Raja, N.U.; Jabbar, M.A. 1993: Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum Journal of Virology 67(9): 5538-5549
Marin, M.H.; Penton, P.C.; Bocalandro, Y.M.; Pena, L.P.; Navarro, J.D.; Lopez, L.J. Gonzalez 2001: Chimeric synthetic peptides from the envelope and the transmembrane glycoproteins for the detection of antibodies to human T-cell leukemia virus type II Biochemical and Biophysical Research Communications 289(1): 7-12
Quan, F-Shi.; Sailaja, G.; Skountzou, I.; Huang, C.; Vzorov, A.; Compans, R.W.; Kang, S-Moo. 2007: Immunogenicity of virus-like particles containing modified human immunodeficiency virus envelope proteins Vaccine 25(19): 3841-3850
Brown, D.T.; Hernandez, R. 2003: Genetically-engineered alphaviruses, flaviviruses, and bunyaviruses with modified envelope transmembrane glycoproteins and altered host-range phenotype Official Gazette of the United States Patent and Trademark Office Patents 1272(2)
Bhattacharya, J.; Peters, P.J.; Clapham, P.R. 2004: Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particles Journal of Virology 78(10): 5500-5506
Gangadhara, S.; Kwon, Y-Man.; Jeeva, S.; Quan, F-Shi.; Wang, B.; Moss, B.; Compans, R.W.; Amara, R.Rao.; Jabbar, M.Abdul.; Kang, S-Moo. 2017: Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins Vaccines 5(4)
Hernández Marin, M.; Castellanos Pentón, P.; Márquez Bocalandro, Y.; Pozo Peña, L.; Díaz Navarro, J.; González López, L.J. 2001: Chimeric synthetic peptides from the envelope (gp46) and the transmembrane (gp21) glycoproteins for the detection of antibodies to human T-cell leukemia virus type Ii Biochemical and Biophysical Research Communications 289(1): 7-12
Ho, D.D.; Sarngadharan, M.G.; Hirsch, M.S.; Schooley, R.T.; Rota, T.R.; Kennedy, R.C.; Chanh, T.C.; Sato, V.L. 1987: Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins Journal of Virology 61(6): 2024-2028
Haglund, K.; Forman, J.; Kräusslich, H.G.; Rose, J.K. 2000: Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope Virology 268(1): 112-121
McKeating, J.A.; Zhang, Y.J.; Arnold, C.; Frederiksson, R.; Fenyö, E.M.; Balfe, P. 1996: Chimeric viruses expressing primary envelope glycoproteins of human immunodeficiency virus type i show increased sensitivity to neutralization by human sera Virology 220(2): 450-460
Cocquerel, L.; Op de Beeck, A.; Lambot, M.; Roussel, J.; Delgrange, D.; Pillez, Aé.; Wychowski, C.; Penin, Fçois.; Dubuisson, J. 2002: Topological changes in the transmembrane domains of hepatitis C virus envelope glycoproteins EMBO Journal 21(12): 2893-2902
Mammano, F.; Kondo, E.; Sodroski, J.; Bukovsky, A.; Göttlinger, H.G. 1995: Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains Journal of Virology 69(6): 3824-3830